Back
Perspective Therapeutics Stock Price Chart
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
23
CATX
Perspective Therapeutics
Last Price:
$2.87
Seasonality Move:
41.25%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.2 | Sell |
| 20-day SMA: | 3.62 | Sell |
| 50-day SMA: | 7.97 | Sell |
| 200-day SMA: | 12.2 | Sell |
| 8-day EMA: | 3.18 | Sell |
| 20-day EMA: | 4.2 | Sell |
| 50-day EMA: | 6.97 | Sell |
| 200-day EMA: | 10.02 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.39 | Sell |
| Relative Strength Index (14 RSI): | 19.38 | Sell |
| Chaikin Money Flow: | -1073375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.81 - 5.45) | Sell |
| Bollinger Bands (100): | (6.71 - 15.03) | Sell |
Perspective Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.85 while CATX 8-day simple moving average is 3.20, which is a Sell signal.
-
The stock price of CATX is 2.85 while Perspective Therapeutics 20-day SMA is 3.62, which makes it a Sell.
-
Perspective Therapeutics 50-day simple moving average is 7.97 while CATX share price is 2.85, making it a Sell technically.
-
CATX stock price is 2.85 and Perspective Therapeutics 200-day simple moving average is 12.20, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
23
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a SellThe current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
192.6M
Price in USD:
2.85
Share Volume:
2.9M
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.70
Sell
23
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?The Perspective Therapeutics stock price is 2.85 USD today.
-
Will CATX stock go up or go down?Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Perspective Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.85 while CATX 8-day exponential moving average is 3.18, which is a Sell signal.
-
The stock price of CATX is 2.85 while Perspective Therapeutics 20-day EMA is 4.20, which makes it a Sell.
-
Perspective Therapeutics 50-day exponential moving average is 6.97 while CATX share price is 2.85, making it a Sell technically.
-
CATX stock price is 2.85 and Perspective Therapeutics 200-day simple moving average is 10.02, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
-
CATX Moving Average Covergence Divergence (MACD) indicator is -1.39, suggesting Perspective Therapeutics is a Sell
-
Perspective Therapeutics Relative Strength Index (RSI) is 19.38, which suggest Perspective Therapeutics is oversold
-
The Bollinger Bands (25) for Perspective Therapeutics is (2.81 - 5.45), which suggest Perspective Therapeutics is a Sell
-
The Bollinger Bands (100) for Perspective Therapeutics is (6.71 - 15.03), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.